
Qian Janice Li
Examiner (ID: 295)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1632 |
| Total Applications | 965 |
| Issued Applications | 436 |
| Pending Applications | 143 |
| Abandoned Applications | 388 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9068159
[patent_doc_number] => 20130259915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-03
[patent_title] => 'METHOD FOR THE TREATMENT OF SKIN'
[patent_app_type] => utility
[patent_app_number] => 13/903412
[patent_app_country] => US
[patent_app_date] => 2013-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2020
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13903412
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/903412 | Method for the treatment of skin | May 27, 2013 | Issued |
Array
(
[id] => 9174022
[patent_doc_number] => 20130316006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-28
[patent_title] => 'PARTICLES, COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/886602
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 77808
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886602
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/886602 | PARTICLES, COMPOSITIONS AND METHODS FOR OPHTHALMIC AND/OR OTHER APPLICATIONS | May 2, 2013 | Abandoned |
Array
(
[id] => 9147891
[patent_doc_number] => 20130302414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE'
[patent_app_type] => utility
[patent_app_number] => 13/872652
[patent_app_country] => US
[patent_app_date] => 2013-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7620
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13872652
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/872652 | SOLUBILIZED CAPSULE FORMULATION OF 1,1-DIMETHYLETHYL [(1S)-1-CARBAMOYL)PYRROLIDIN-1-YL]CARBONYL}-2,2-DIMETHYLPROPYL]CARBAMATE | Apr 28, 2013 | Abandoned |
Array
(
[id] => 9397074
[patent_doc_number] => 20140094481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 13/866828
[patent_app_country] => US
[patent_app_date] => 2013-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8490
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13866828
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/866828 | TAMPER RESISTANT DOSAGE FORMS | Apr 18, 2013 | Abandoned |
Array
(
[id] => 9107044
[patent_doc_number] => 20130280176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Immediate Release Pharmaceutical Compositions with Abuse Deterrent Properties'
[patent_app_type] => utility
[patent_app_number] => 13/865244
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10805
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865244
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/865244 | Immediate Release Pharmaceutical Compositions with Abuse Deterrent Properties | Apr 17, 2013 | Abandoned |
Array
(
[id] => 9016352
[patent_doc_number] => 20130231316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-05
[patent_title] => 'Drug Combination Comprising a Selective Serotonin Reuptake Inhibitor and a Glucocorticoid Receptor Antagonist for the Treatment of Depression'
[patent_app_type] => utility
[patent_app_number] => 13/865259
[patent_app_country] => US
[patent_app_date] => 2013-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2860
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865259
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/865259 | Drug Combination Comprising a Selective Serotonin Reuptake Inhibitor and a Glucocorticoid Receptor Antagonist for the Treatment of Depression | Apr 17, 2013 | Abandoned |
Array
(
[id] => 9134429
[patent_doc_number] => 20130295143
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'ELECTROPROCESSING OF ACTIVE PHARMACEUTICAL INGREDIENTS'
[patent_app_type] => utility
[patent_app_number] => 13/832812
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 15078
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13832812
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/832812 | ELECTROPROCESSING OF ACTIVE PHARMACEUTICAL INGREDIENTS | Mar 14, 2013 | Abandoned |
Array
(
[id] => 8989337
[patent_doc_number] => 20130216618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => 'SOFT CAPSULE BASED ON STARCH AND A METHOD AND DEVICE FOR THE PRODUCTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/839426
[patent_app_country] => US
[patent_app_date] => 2013-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15172
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13839426
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/839426 | Soft capsule based on starch and a method and device for the production thereof | Mar 14, 2013 | Issued |
Array
(
[id] => 9656320
[patent_doc_number] => 20140227325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'LIGNIN-DERIVED POROUS CARBON COMPOSITION, METHODS OF PREPARATION, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/766292
[patent_app_country] => US
[patent_app_date] => 2013-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18280
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13766292
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/766292 | LIGNIN-DERIVED POROUS CARBON COMPOSITION, METHODS OF PREPARATION, AND USE THEREOF | Feb 12, 2013 | Abandoned |
Array
(
[id] => 8939550
[patent_doc_number] => 20130189347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'DISEASE TREATMENT DRUG'
[patent_app_type] => utility
[patent_app_number] => 13/752963
[patent_app_country] => US
[patent_app_date] => 2013-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7473
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13752963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/752963 | DISEASE TREATMENT DRUG | Jan 28, 2013 | Abandoned |
Array
(
[id] => 8939572
[patent_doc_number] => 20130189369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-25
[patent_title] => 'TIME RELEASED BIODEGRADABLE OR BIOERODIBLE MICROSPHERES OR MICROPARTICLES SUSPENDED IN A SOLIDIFYING DEPOT-FORMING INJECTABLE DRUG FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 13/746592
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5520
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746592
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/746592 | TIME RELEASED BIODEGRADABLE OR BIOERODIBLE MICROSPHERES OR MICROPARTICLES SUSPENDED IN A SOLIDIFYING DEPOT-FORMING INJECTABLE DRUG FORMULATION | Jan 21, 2013 | Abandoned |
Array
(
[id] => 8950150
[patent_doc_number] => 20130195930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Inulin and Inulin Acetate Formulations'
[patent_app_type] => utility
[patent_app_number] => 13/746492
[patent_app_country] => US
[patent_app_date] => 2013-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 18949
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746492
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/746492 | Inulin and Inulin Acetate Formulations | Jan 21, 2013 | Abandoned |
Array
(
[id] => 9562063
[patent_doc_number] => 20140179777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-26
[patent_title] => 'TASTE-MASKED DOCUSATE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/745594
[patent_app_country] => US
[patent_app_date] => 2013-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3803
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13745594
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/745594 | TASTE-MASKED DOCUSATE COMPOSITIONS | Jan 17, 2013 | Abandoned |
Array
(
[id] => 8950175
[patent_doc_number] => 20130195955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-01
[patent_title] => 'Implants Containing BMP-7'
[patent_app_type] => utility
[patent_app_number] => 13/724660
[patent_app_country] => US
[patent_app_date] => 2012-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4333
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13724660
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/724660 | Implants Containing BMP-7 | Dec 20, 2012 | Abandoned |
Array
(
[id] => 8791706
[patent_doc_number] => 20130108675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'ORGANIC COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/721278
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6817
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13721278
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/721278 | ORGANIC COMPOUNDS | Dec 19, 2012 | Abandoned |
Array
(
[id] => 8828778
[patent_doc_number] => 20130129823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR GLUCOCORTICOID REPLACEMENT THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/722013
[patent_app_country] => US
[patent_app_date] => 2012-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 15055
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13722013
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/722013 | PHARMACEUTICAL COMPOSITIONS FOR GLUCOCORTICOID REPLACEMENT THERAPY | Dec 19, 2012 | Abandoned |
Array
(
[id] => 10467039
[patent_doc_number] => 20150352054
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2015-12-10
[patent_title] => 'Enteric Soft Capsules'
[patent_app_type] => utility
[patent_app_number] => 13/693332
[patent_app_country] => US
[patent_app_date] => 2012-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5685
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13693332
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/693332 | Enteric soft capsules | Dec 3, 2012 | Issued |
Array
(
[id] => 10467039
[patent_doc_number] => 20150352054
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2015-12-10
[patent_title] => 'Enteric Soft Capsules'
[patent_app_type] => utility
[patent_app_number] => 13/693332
[patent_app_country] => US
[patent_app_date] => 2012-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5685
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13693332
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/693332 | Enteric soft capsules | Dec 3, 2012 | Issued |
Array
(
[id] => 8928439
[patent_doc_number] => 20130184198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-18
[patent_title] => 'Pulmonary Surfactant Formulations'
[patent_app_type] => utility
[patent_app_number] => 13/689341
[patent_app_country] => US
[patent_app_date] => 2012-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28719
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13689341
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/689341 | Pulmonary Surfactant Formulations | Nov 28, 2012 | Abandoned |
Array
(
[id] => 8828747
[patent_doc_number] => 20130129791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING SECOND AND THIRD GENERATION CEPHALOSPORIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/668922
[patent_app_country] => US
[patent_app_date] => 2012-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11757
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668922
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/668922 | PREPARATIONS OF EFFERVESCENT FORMULATIONS COMPRISING SECOND AND THIRD GENERATION CEPHALOSPORIN AND USES THEREOF | Nov 4, 2012 | Abandoned |